Cargando…

The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-γ release by natural killer cells

OBJECTIVES: We evaluated the antibody response, natural killer cell response and B cell phenotypes in healthcare workers (HCW) who are vaccinated with two doses of CoronaVac with or without documented SARS-CoV-2 infection and unvaccinated HCWs with SARS-CoV-2 infection. METHODS: HCWs were divided in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bilgin, Huseyin, Marku, Marisa, Yilmaz, Sultan Seval, Karahasan Yagci, Aysegul, Sili, Uluhan, Can, Baris, Can Sarinoglu, Rabia, Mulazimoglu Durmusoglu, Lutfiye, Haklar, Goncagul, Sirikci, Onder, Eksioglu Demiralp, Emel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930391/
https://www.ncbi.nlm.nih.gov/pubmed/35339303
http://dx.doi.org/10.1016/j.vaccine.2022.03.001
_version_ 1784671055656255488
author Bilgin, Huseyin
Marku, Marisa
Yilmaz, Sultan Seval
Karahasan Yagci, Aysegul
Sili, Uluhan
Can, Baris
Can Sarinoglu, Rabia
Mulazimoglu Durmusoglu, Lutfiye
Haklar, Goncagul
Sirikci, Onder
Eksioglu Demiralp, Emel
author_facet Bilgin, Huseyin
Marku, Marisa
Yilmaz, Sultan Seval
Karahasan Yagci, Aysegul
Sili, Uluhan
Can, Baris
Can Sarinoglu, Rabia
Mulazimoglu Durmusoglu, Lutfiye
Haklar, Goncagul
Sirikci, Onder
Eksioglu Demiralp, Emel
author_sort Bilgin, Huseyin
collection PubMed
description OBJECTIVES: We evaluated the antibody response, natural killer cell response and B cell phenotypes in healthcare workers (HCW) who are vaccinated with two doses of CoronaVac with or without documented SARS-CoV-2 infection and unvaccinated HCWs with SARS-CoV-2 infection. METHODS: HCWs were divided into four groups: vaccine only (VO), vaccine after SARS-CoV-2 infection (VAI), SARS-CoV-2 infection only (IO), and SARS-CoV-2 infection after vaccine (IAV). Anti-SARS-CoV-2 spike protein (Anti-S) antibodies were measured by Elecsys Anti–SARS–CoV–2 S ELISA kit. Memory B cells (CD19(+)CD27(+)), plasmablast B cells (CD19(+)CD138(+)) and long-lived plasma cells (LLPC; CD138(+)CD19(-)) were measured by flow cytometry in 74 patients. Interferon gamma (IFN-γ) release by natural killer (NK) cells were measured by NKVue Test (NKMAX, Republic of Korea) in 76 patients. RT-PCR was performed with Bio-speedy® COVID-19 qPCR detection kit, Version 2 (Bioexen LTD, Istanbul, Turkey). RESULTS: The Anti-S antibodies were detectable in all HCWs (n: 224). The median Anti-S titers (BAU/mL) was significantly higher in VAI (620 25–75% 373–1341) compared to VO (136, 25–75% 85–283) and IO (111, 25–75% 54–413, p < 0.01). VAI group had significantly lower percentage of plasmablasts (2.9; 0–8.7) compared to VO (6.8; 3.5–12.0) and IO (9.9; 4.7–47.5, p < 0.01) (n:74). Percentage of LLPCs in groups VO, VAI and IO was similar. There was no difference of IFN-γ levels between the study groups (n: 76). CONCLUSION: The antibody response was similar between uninfected vaccinated HCWs and unvaccinated HCWs who had natural infection. HCWs who had two doses of CoronaVac either before or after the natural SARS-CoV-2 infection elicited significantly higher antibody responses compared to uninfected vaccinated HCWs. The lower percentages of plasmablasts in the VAI group may indicate their migration to lymph nodes and initiation of the germinal center reaction phase. IFN-γ response did not differ among the groups.
format Online
Article
Text
id pubmed-8930391
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-89303912022-03-18 The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-γ release by natural killer cells Bilgin, Huseyin Marku, Marisa Yilmaz, Sultan Seval Karahasan Yagci, Aysegul Sili, Uluhan Can, Baris Can Sarinoglu, Rabia Mulazimoglu Durmusoglu, Lutfiye Haklar, Goncagul Sirikci, Onder Eksioglu Demiralp, Emel Vaccine Article OBJECTIVES: We evaluated the antibody response, natural killer cell response and B cell phenotypes in healthcare workers (HCW) who are vaccinated with two doses of CoronaVac with or without documented SARS-CoV-2 infection and unvaccinated HCWs with SARS-CoV-2 infection. METHODS: HCWs were divided into four groups: vaccine only (VO), vaccine after SARS-CoV-2 infection (VAI), SARS-CoV-2 infection only (IO), and SARS-CoV-2 infection after vaccine (IAV). Anti-SARS-CoV-2 spike protein (Anti-S) antibodies were measured by Elecsys Anti–SARS–CoV–2 S ELISA kit. Memory B cells (CD19(+)CD27(+)), plasmablast B cells (CD19(+)CD138(+)) and long-lived plasma cells (LLPC; CD138(+)CD19(-)) were measured by flow cytometry in 74 patients. Interferon gamma (IFN-γ) release by natural killer (NK) cells were measured by NKVue Test (NKMAX, Republic of Korea) in 76 patients. RT-PCR was performed with Bio-speedy® COVID-19 qPCR detection kit, Version 2 (Bioexen LTD, Istanbul, Turkey). RESULTS: The Anti-S antibodies were detectable in all HCWs (n: 224). The median Anti-S titers (BAU/mL) was significantly higher in VAI (620 25–75% 373–1341) compared to VO (136, 25–75% 85–283) and IO (111, 25–75% 54–413, p < 0.01). VAI group had significantly lower percentage of plasmablasts (2.9; 0–8.7) compared to VO (6.8; 3.5–12.0) and IO (9.9; 4.7–47.5, p < 0.01) (n:74). Percentage of LLPCs in groups VO, VAI and IO was similar. There was no difference of IFN-γ levels between the study groups (n: 76). CONCLUSION: The antibody response was similar between uninfected vaccinated HCWs and unvaccinated HCWs who had natural infection. HCWs who had two doses of CoronaVac either before or after the natural SARS-CoV-2 infection elicited significantly higher antibody responses compared to uninfected vaccinated HCWs. The lower percentages of plasmablasts in the VAI group may indicate their migration to lymph nodes and initiation of the germinal center reaction phase. IFN-γ response did not differ among the groups. Elsevier Ltd. 2022-04-20 2022-03-18 /pmc/articles/PMC8930391/ /pubmed/35339303 http://dx.doi.org/10.1016/j.vaccine.2022.03.001 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Bilgin, Huseyin
Marku, Marisa
Yilmaz, Sultan Seval
Karahasan Yagci, Aysegul
Sili, Uluhan
Can, Baris
Can Sarinoglu, Rabia
Mulazimoglu Durmusoglu, Lutfiye
Haklar, Goncagul
Sirikci, Onder
Eksioglu Demiralp, Emel
The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-γ release by natural killer cells
title The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-γ release by natural killer cells
title_full The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-γ release by natural killer cells
title_fullStr The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-γ release by natural killer cells
title_full_unstemmed The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-γ release by natural killer cells
title_short The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-γ release by natural killer cells
title_sort effect of immunization with inactivated sars-cov-2 vaccine (coronavac) and/or sars-cov-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and ifn-γ release by natural killer cells
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8930391/
https://www.ncbi.nlm.nih.gov/pubmed/35339303
http://dx.doi.org/10.1016/j.vaccine.2022.03.001
work_keys_str_mv AT bilginhuseyin theeffectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT markumarisa theeffectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT yilmazsultanseval theeffectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT karahasanyagciaysegul theeffectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT siliuluhan theeffectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT canbaris theeffectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT cansarinoglurabia theeffectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT mulazimogludurmusoglulutfiye theeffectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT haklargoncagul theeffectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT sirikcionder theeffectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT eksiogludemiralpemel theeffectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT bilginhuseyin effectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT markumarisa effectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT yilmazsultanseval effectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT karahasanyagciaysegul effectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT siliuluhan effectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT canbaris effectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT cansarinoglurabia effectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT mulazimogludurmusoglulutfiye effectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT haklargoncagul effectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT sirikcionder effectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells
AT eksiogludemiralpemel effectofimmunizationwithinactivatedsarscov2vaccinecoronavacandorsarscov2infectiononantibodylevelsplasmablastslonglivedplasmacellsandifngreleasebynaturalkillercells